Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
161 hedge funds and large institutions have $815M invested in Meridian Bioscience Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 51 increasing their positions, 66 reducing their positions, and 23 closing their positions.
4% less capital invested
Capital invested by funds: $851M → $815M (-$36M)
3% less funds holding
Funds holding: 166 → 161 (-5)
17% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 23
23% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 66
71% less call options, than puts
Call options by funds: $469K | Put options by funds: $1.62M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
+$8.51M |
| 2 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$6.9M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$5.56M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.09M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$4.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Cincinnati Insurance
Fairfield,
Ohio
|
-$15.9M |
| 2 |
Neuberger Berman Group
New York
|
-$5.81M |
| 3 |
CFC
Cincinnati Financial Corp
Fairfield,
Ohio
|
-$5.01M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$3.34M |
| 5 |
HNB
Huntington National Bank
Columbus,
Ohio
|
-$2.25M |
VIVO Hedge Fund Activity: Q2 2014 in Review
161 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2014, worth a combined $815M — down 4.2% from $851M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of VIVO and 19 opened new positions — a net loss of 4 holders — while 66 trimmed existing stakes and 51 added.
The largest buyer was Perkins Investment Management, adding an estimated $8.51M. The largest seller was Cincinnati Insurance, exiting entirely with an estimated $15.9M sold.
- 161 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2014, down from 166 in Q1 2014.
- Funds reported $815M of Meridian Bioscience Inc stock for Q2 2014, down 4.2% quarter-over-quarter.
- 19 funds opened new Meridian Bioscience Inc positions in Q2 2014 and 23 closed out, a net change of -4 holders.
- The largest Meridian Bioscience Inc buyer in Q2 2014 was Perkins Investment Management, an estimated $8.51M added.
- The largest Meridian Bioscience Inc seller in Q2 2014 was Cincinnati Insurance, an estimated $15.9M sold.
Based on aggregated 13F filings for Q2 2014.